Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Embecta Corp. in the United States District Court for the District of New Jersey. The suit represents investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The complaint alleges that the company made materially false and misleading statements about its fiscal results and guidance, particularly regarding its pen needle business. On May 5, 2026, Embecta reported second-quarter earnings below expectations and cut its full-year 2026 guidance, citing a loss in its pen needle product category and market volume softness, causing shares to drop approximately 58% from $9.25 to $3.90. Investors have until August 17, 2026 to seek lead plaintiff appointment.
Embecta CorpClass action lawsuit alleging false statements about fiscal results and guidance, plus earnings miss and guidance cut causing 58% share drop.